Our Faculty

Derick E. Vergne, M.D.

Derick E. Vergne, M.D.

Tufts University School of Medicine; Assistant Professor

Biography

Dr. Derick E. Vergne is a board-certified psychiatrist with a strong background in clinical practice and research. He earned his MD from the University of Puerto Rico in 2002 and completed his psychiatric training at the University of Colorado and Emory University. He serves as Assistant Professor of Psychiatry at Tufts University School of Medicine.

Dr. Vergne combines a psychodynamic and psychoanalytic approach to neuropsychopharmacology to enhance his understanding of patients. He has published work on mood and anxiety disorders, trauma, and alcoholism. Bilingual in English and Spanish, Dr. Vergne is a member of several professional societies and currently practices in Acton, MA.

Publications of Derick E. Vergne, M.D.

Quick Take Vol. 80

0.75 CMEs
How effective is the new antipsychotic KarXT using the number needed to treat metric? Can bright light therapy effectively treat bipolar depression without causing mania? Does IV haloperidol really increase cardiac risks as commonly believed? Can varenicline help reduce alcohol intake in people with alcohol use disorder? Does ashwagandha extract improve cognitive function in mild cognitive impairment?
Faculty: Oliver Freudenreich, M.D., Kristin Raj, M.D., Scott R. Beach, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Derick E. Vergne, M.D.
39.35 minutes in 5 audio sections

Quick Take Vol. 79

0.75 CMEs
How should clozapine monitoring change after FDA's REMS removal? Does cariprazine work equally well in older adults with bipolar disorder? Can semaglutide help treat alcohol use disorder? Why do older adults receive subtherapeutic antidepressant doses? Is saffron as effective as SSRIs for depression?
Faculty: Scott R. Beach, M.D., Oliver Freudenreich, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Kristin Raj, M.D., Derick E. Vergne, M.D.
44.22 minutes in 5 audio sections

Quick Take Vol. 78

0.50 CMEs
Can pramipexole help treatment-resistant bipolar depression? Does semaglutide work for clozapine-induced obesity? Which antipsychotics best prevent hospitalization after cannabis-induced psychosis? What treatments rank highest for treatment-resistant depression? How do gut microbiota differ in depression versus anxiety disorders?
Faculty: Kristin Raj, M.D., Oliver Freudenreich, M.D., Paul Zarkowski, M.D., Derick E. Vergne, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.
34.08 minutes in 5 audio sections

Quick Take Vol. 77

0.75 CMEs
What is the best antipsychotic for first-episode psychosis? Can lurasidone treat bipolar depression with severe anxiety? How much do SSRIs increase bleeding when combined with anticoagulants? Is adding salt to meals associated with depression and anxiety?
Faculty: Scott R. Beach, M.D., Paul Zarkowski, M.D., Oliver Freudenreich, M.D., Kristin Raj, M.D., Derick E. Vergne, M.D.
39.21 minutes in 5 audio sections

Quick Take Vol. 76

0.75 CMEs
Can lumateperone effectively treat depression with mixed features? Can GLP-1 agonists manage antipsychotic-induced weight gain? Is quetiapine superior to lithium for treatment-resistant depression? Do antidepressants accelerate cognitive decline in dementia patients? How do probiotics and prebiotics affect depression, anxiety, and cognition?
Faculty: Scott R. Beach, M.D., Paul Zarkowski, M.D., Oliver Freudenreich, M.D., Kristin Raj, M.D., Derick E. Vergne, M.D.
44.56 minutes in 5 audio sections

Quick Take Vol. 75

0.75 CMEs
What are the main considerations when choosing an antipsychotic for first-episode psychosis? How do side effects of antidepressants change over time? Do combinations of psychiatric medications increase Torsades risk? Is there sufficient evidence for psychedelics in treating substance use disorders? Can tea compounds benefit mood and sleep disorders through neurotransmitter modulation?
Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Scott R. Beach, M.D., Paul Zarkowski, M.D., Oliver Freudenreich, M.D., Derick E. Vergne, M.D.
40.11 minutes in 5 audio sections

Quick Take Vol. 73

0.75 CMEs
How do LAI antipsychotics impact mortality rates compared to oral medications in schizophrenia ? What dosages of medications are most effective for preventing bipolar disorder relapse and maintaining safety? Is olanzapine more effective than risperidone for managing BPS? Can lisdexamfetamine effectively treat methamphetamine use disorder? Does chronopharmacology impact psychiatric treatment efficacy and side effects?
Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Scott R. Beach, M.D., Oliver Freudenreich, M.D., Kristin Raj, M.D., Derick E. Vergne, M.D.
43.14 minutes in 5 audio sections

Quick Take Vol. 71

0.75 CMEs
What are the major risks of antipsychotic pneumonia and which medications increase this risk? How effective is metformin combined with lifestyle changes for managing antipsychotic-induced weight gain? What are the optimal lithium levels for maintenance treatment and acute mania? How does exercise potentially help improve depression symptoms through biological mechanisms? What role do B-complex vitamins play in cognitive function among depressed patients?
Faculty: Scott R. Beach, M.D., Paul Zarkowski, M.D., Derick E. Vergne, M.D.
39.46 minutes in 5 audio sections

Quick Take Vol. 70

0.50 CMEs
How does clozapine affect OCD behaviors in schizophrenia patients? What is the relationship between valproate dosage and weight gain? Which dopamine agonist works best for treatment-resistant depression? Does delirium increase dementia risk in elderly patients? What treatment approaches show the strongest evidence for stimulant use disorder?
Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Scott R. Beach, M.D., Paul Zarkowski, M.D., Oliver Freudenreich, M.D., Derick E. Vergne, M.D.
36.51 minutes in 5 audio sections

Explore our library of over 440 video lectures, podcasts, research summaries and expert interviews.